{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T13:50:45Z","timestamp":1789912245246,"version":"4.0.1"},"reference-count":48,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1097\/mop.0b013e3282f161dc","type":"journal-article","created":{"date-parts":[[2009,3,4]],"date-time":"2009-03-04T20:45:47Z","timestamp":1236199547000},"page":"636-644","source":"Crossref","is-referenced-by-count":44,"title":["Costello syndrome and related disorders"],"prefix":"10.1097","volume":"19","author":[{"given":"Emilio","family":"Quezada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen W","family":"Gripp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-6-20210206","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/ajmg.c.10019","article-title":"Costello syndrome: an overview","volume":"117C","author":"Hennekam","year":"2003","journal-title":"Am J Med Genet"},{"key":"R3-6-20210206","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/ajmg.c.30065","article-title":"Tumor predisposition in Costello syndrome","volume":"137C","author":"Gripp","year":"2005","journal-title":"Am J Med Genet"},{"key":"R4-6-20210206","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/ajmg.10241","article-title":"Five additional Costello syndrome patients with rhabdomyosarcoma: proposal for a tumor screening protocol","volume":"108","author":"Gripp","year":"2002","journal-title":"Am J Med Genet"},{"key":"R8-6-20210206","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/ajmg.a.30189","article-title":"Costello syndrome with growth hormone deficiency and hypoglycemia: a new report and review of the endocrine associations","volume":"129A","author":"Gregersen","year":"2004","journal-title":"Am J Med Genet"},{"key":"R9-6-20210206","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/ajmg.a.31011","article-title":"Costello syndrome and hyperinsulinemic hypoglycemia","volume":"139A","author":"Alexander","year":"2005","journal-title":"Am J Med Genet"},{"key":"R10-6-20210206","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/BF03345551","article-title":"The IGF system in a case of Costello syndrome","volume":"29","author":"Barreca","year":"2006","journal-title":"J Endocrinol Invest"},{"key":"R11-6-20210206","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/ajmg.a.20330","article-title":"Costello syndrome and neurological abnormalities","volume":"123A","author":"Delrue","year":"2003","journal-title":"Am J Med Genet"},{"key":"R12-6-20210206","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ajmg.a.31047","article-title":"HRAS mutation analysis in Costello syndrome: genotype and phenotype correlation","volume":"140A","author":"Gripp","year":"2006","journal-title":"Am J Med Genet"},{"key":"R13-6-20210206","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/ajmg.a.30140","article-title":"Adaptive skills, cognitive, and behavioral characteristics of Costello syndrome","volume":"128A","author":"Axelrad","year":"2004","journal-title":"Am J Med Genet"},{"key":"R15-6-20210206","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/ajmg.a.30747","article-title":"The adult phenotype in Costello syndrome","volume":"136A","author":"White","year":"2005","journal-title":"Am J Med Genet"},{"key":"R16-6-20210206","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1002\/ajmg.a.31815","article-title":"Further delineation of the phenotype resulting from BRAF or MEK1 germline mutations helps differentiate cardio-facio-cutaneous syndrome from Costello syndrome","volume":"143A","author":"Gripp","year":"2007","journal-title":"Am J Med Genet"},{"key":"R17-6-20210206","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/ajmg.10558","article-title":"Further delineation of cardiac abnormalities in Costello syndrome","volume":"111","author":"Lin","year":"2002","journal-title":"Am J Med Genet"},{"key":"R18-6-20210206","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/ajmg.a.30100","article-title":"Elevated catecholamine metabolites in patients with Costello syndrome","volume":"128A","author":"Gripp","year":"2004","journal-title":"Am J Med Genet"},{"key":"R19-6-20210206","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1038\/ng1641","article-title":"Germline mutations in HRAS proto-oncogene cause Costello syndrome","volume":"37","author":"Aoki","year":"2005","journal-title":"Nat Genet"},{"key":"R20-6-20210206","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1515\/BC.2005.025","article-title":"Oncogenic Ras in tumor progression and metastasis","volume":"386","author":"Giehl","year":"2005","journal-title":"Biol Chem"},{"key":"R21-6-20210206","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/ajmg.a.31078","article-title":"HRAS mutations in Costello syndrome: detection of constitutional activating mutations in codon 12 and 13 and loss of wild-type allele in malignancy","volume":"140A","author":"Estep","year":"2005","journal-title":"Am J Med Genet"},{"key":"R22-6-20210206","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1136\/jmg.2005.040352","article-title":"Genotype-phenotype correlation in Costello syndrome; HRAS mutation analysis in 43 cases","volume":"43","author":"Kerr","year":"2006","journal-title":"J Med Genet"},{"key":"R23-6-20210206","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1002\/humu.20381","article-title":"Paternal bias in parental origin of HRAS mutations in Costello syndrome","volume":"27","author":"Sol-Church","year":"2006","journal-title":"Hum Mutat"},{"key":"R24-6-20210206","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/j.1600-0625.2006.00474.x","article-title":"Recurring HRAS mutation G12S in Dutch patients with Costello syndrome","volume":"15","author":"Van Steensel","year":"2006","journal-title":"Exp Dermatol"},{"key":"R25-6-20210206","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/humu.20431","article-title":"Diversity, parental germline origin, and phenotypic spectrum of de novo HRAS missense changes in Costello syndrome","volume":"28","author":"Zampino","year":"2007","journal-title":"Hum Mutat"},{"key":"R26-6-20210206","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1399-0004.2007.00743.x","article-title":"HRAS and the Costello syndrome","volume":"71","author":"Rauen","year":"2007","journal-title":"Clin Genet"},{"key":"R27-6-20210206","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1002\/ajmg.a.31456","article-title":"Somatic mosaicism for an HRAS mutation causes Costello syndrome","volume":"140A","author":"Gripp","year":"2006","journal-title":"Am J Med Genet"},{"key":"R28-6-20210206","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1136\/jmg.2007.049270","article-title":"Myopathy caused by HRAS germline mutations \u2013 implications on disturbed myogenic differentiation in the presence of constitutive H-Ras activation","volume":"44","author":"Van der Burgt","year":"2007","journal-title":"J Med Genet"},{"key":"R29-6-20210206","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1136\/jmg.2006.042796","article-title":"The cardiofaciocutaneous syndrome","volume":"43","author":"Roberts","year":"2006","journal-title":"J Med Genet"},{"key":"R30-6-20210206","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/ng1749","article-title":"Germline KRAS and BRAF mutations in cardio-facio-cutaneous syndrome","volume":"38","author":"Niihori","year":"2006","journal-title":"Nat Genet"},{"key":"R31-6-20210206","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1126\/science.1124642","article-title":"Germline mutations in genes within the MAPK pathway cause cardio-facio-cutaneous syndrome","volume":"311","author":"Rodriguez-Viciana","year":"2006","journal-title":"Science"},{"key":"R32-6-20210206","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1002\/ajmg.a.31658","article-title":"Molecular and clinical characterization of cardio-facio-cutaneous (CFC) syndrome: overlapping clinical manifestations with Costello syndrome","volume":"143A","author":"Narumi","year":"2007","journal-title":"Am J Med Genet"},{"key":"R33-6-20210206","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1002\/ajmg.a.31315","article-title":"Distinguishing Costello versus cardio-facio-cutaneous syndrome: BRAF mutations in patients with a Costello phenotype","volume":"140A","author":"Rauen","year":"2006","journal-title":"Am J Med Genet"},{"key":"R34-6-20210206","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1002\/ajmg.a.31819","article-title":"Hepatoblastoma and heart transplantation in a patient with cardio-facio-cutaneous syndrome","volume":"143A","author":"Al-Rahawan","year":"2007","journal-title":"Am J Med Genet"},{"key":"R35-6-20210206","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/ng772","article-title":"Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome","volume":"29","author":"Tartaglia","year":"2001","journal-title":"Nat Genet"},{"key":"R36-6-20210206","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1002\/gcc.20322","article-title":"Mutations of the PTPN11 and RAS genes in rhabdomyosarcoma and pediatric hematological malignancies","volume":"45","author":"Chen","year":"2006","journal-title":"Genes Chromosomes Cancer"},{"key":"R37-6-20210206","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/ng1156","article-title":"Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia","volume":"34","author":"Tartaglia","year":"2003","journal-title":"Nat Genet"},{"key":"R38-6-20210206","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/ng1926","article-title":"Germline gain-of-function mutations in SOS1 cause Noonan syndrome","volume":"39","author":"Roberts","year":"2007","journal-title":"Nat Genet"},{"key":"R39-6-20210206","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/ng1939","article-title":"Gain-of function SOS1 mutations cause a distinctive form of Noonan syndrome","volume":"39","author":"Tartaglia","year":"2007","journal-title":"Nat Genet"},{"key":"R40-6-20210206","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/ng2073","article-title":"Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy","volume":"39","author":"Pandit","year":"2007","journal-title":"Nat Genet"},{"key":"R41-6-20210206","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/ng2078","article-title":"Germline gain-of-function mutations in RAF1 cause Noonan syndrome","volume":"39","author":"Razzaque","year":"2007","journal-title":"Nat Genet"},{"key":"R42-6-20210206","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1002\/ajmg.a.31666","article-title":"Clinical lumping and molecular splitting of LEOPARD and NF1\/NF1\u2013Noonan syndromes","volume":"143A","author":"Sarkozy","year":"2007","journal-title":"Am J Med Genet"},{"key":"R43-6-20210206","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/ng1748","article-title":"Germline KRAS mutations cause Noonan syndrome","volume":"38","author":"Schubbert","year":"2006","journal-title":"Nat Genet"},{"key":"R44-6-20210206","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1086\/504394","article-title":"Germline missense mutations affecting KRAS isoforms B are associated with a severe Noonan syndrome phenotype","volume":"79","author":"Carta","year":"2006","journal-title":"Am J Hum Genet"},{"key":"R45-6-20210206","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1136\/jmg.2006.046300","article-title":"Expansion of the genotypic and phenotypic spectrum in patients with KRAS germline mutations","volume":"44","author":"Zenker","year":"2007","journal-title":"J Med Genet"},{"key":"R47-6-20210206","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1399-0004.1996.tb04328.x","article-title":"Neurofibromatosis\/Noonan phenotype: a variable feature of type 1 neurofibromatosis","volume":"49","author":"Colley","year":"1996","journal-title":"Clin Genet"},{"key":"R48-6-20210206","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1399-0004.2006.00576.x","article-title":"Clinical and molecular aspects of an informative family with neurofibromatosis type 1 and Noonan phenotype","volume":"69","author":"Stevenson","year":"2006","journal-title":"Clin Genet"},{"key":"R49-6-20210206","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00109-006-0135-4","article-title":"An unexpected new role of mutant Ras: perturbation of human embryonic development","volume":"85","author":"Kratz","year":"2007","journal-title":"J Mol Med"},{"key":"R50-6-20210206","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.4161\/cc.5.15.3128","article-title":"Germline mutations in components of the Ras signaling pathway in Noonan syndrome and related disorders","volume":"5","author":"Kratz","year":"2006","journal-title":"Cell Cycle"},{"key":"R51-6-20210206","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/nm0306-283","article-title":"Stops along the RAS pathway in human genetic disease","volume":"12","author":"Bentires-Alj","year":"2006","journal-title":"Nat Med"},{"key":"R52-6-20210206","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ejmg.2006.12.003","article-title":"Distal phalangeal creases \u2013 a distinctive dysmorphic feature in disorders of the RAS signaling pathway","volume":"50","author":"\u00d8rstavik","year":"2007","journal-title":"Eur J Med Genet"},{"key":"R53-6-20210206","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nrc2109","article-title":"Hyperactive Ras in developmental disorders and cancer","volume":"7","author":"Schubbert","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"R54-6-20210206","doi-asserted-by":"crossref","first-page":"6785","DOI":"10.1074\/jbc.M513068200","article-title":"PTPN11 (Shp2) mutations in LEOPARD syndrome have dominant negative, not activating, effects","volume":"281","author":"Kontaridis","year":"2006","journal-title":"J Biol Chem"}],"container-title":["Current Opinion in Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MOP.0b013e3282f161dc","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:42:34Z","timestamp":1786038154000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00008480-200712000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":48,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/mop.0b013e3282f161dc","relation":{},"ISSN":["1040-8703"],"issn-type":[{"value":"1040-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2007,12]]}}}